(Press-News.org) LOS ANGELES (March 15, 2012) - In the past decade, results from large prospective cohort studies and the Women's Health Initiative (WHI) randomized placebo-controlled hormone therapy trials have substantially changed thoughts about how estrogen alone and estrogen plus progestin influence the risk of breast cancer, according to a review published TK in the Journal of The National Cancer Institute.
Although hormone therapy is currently used by millions of women for menopausal symptoms, there is still concern about hormone therapy–induced breast cancer risk. In addition, the effects of estrogen plus progestin versus estrogen alone on breast cancer are not completely understood.
To compare the effects of estrogen alone versus those of estrogen plus progestin on breast cancer risk, Rowan T. Chlebowski, M.D., Ph.D., of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and Garnet Anderson, Ph.D., at Fred Hutchinson Cancer Research Center, looked at data from two randomized, placebo-controlled full scale clinical trials conducted in the WHI. One trial evaluated estrogen plus progestin in postmenopausal women with an intact uterus, and the other evaluated estrogen alone in postmenopausal women with prior hysterectomy. Estrogen plus progestin statistically significantly increased the risk of breast cancer. In contrast, estrogen alone use in postmenopausal women with a previous hysterectomy, statistically significantly decreased the risk of breast cancer.
The randomized clinical trial findings differ from the predominance of observational studies, which suggested that both estrogen alone and estrogen plus progestin increase breast cancer incidence. Dr. Chlebowksi explains that "an imbalance in the use of mammography with greater screening for hormone users could explain some of the increase in breast cancer incidence with estrogen alone seen in cohort studies because screened populations have more cancers detected than unscreened populations."
While the mechanisms underlying the different effects of estrogen alone and estrogen plus progestin are not completely understood, the authors state that preclinical and other clinical evidence suggests "the findings in the clinic, taken together with preclinical evidence, indicate that many breast cancers in post-menopausal women can survive only a limited range of estrogen exposures."
### About LA BioMed
Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and cures for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit www.LABioMed.org
Dr. Rowan Chlebowski: Effects of estrogen alone vs. estrogen plus progestin on breast cancer risk
Menopausal hormone therapy and breast cancer risk: Emerging evidence from randomized trials
2012-03-19
ELSE PRESS RELEASES FROM THIS DATE:
Fraser Yachts: Superyachts for Sale This Summer 2012
2012-03-19
Fraser Yachts has a fantastic portfolio of luxury yachts for sale, four of which can be viewed at this year's Antibes Yacht Show (April 12-15th). Fraser Yachts brokers will, of course, be in attendance with M/Y LIVIA, M/Y BEYOND, M/Y VOYAGER and S/Y ALIA 82.
Built in 2009 by the respected Moonen shipyard, the motor yacht LIVIA is a 30m yacht for sale exclusively through Fraser Yachts. Exquisitely appointed throughout she can accommodate up to eight guests and four crew in modern, spacious living quarters. Sail round the Mediterranean this summer at a comfortable 12 ...
Wild orangutans stressed by eco-tourists, but not for long, IU study out of north Borneo finds
2012-03-19
BLOOMINGTON, Ind. -- Wild orangutans that have come into contact with eco-tourists over a period of years show an immediate stress response but no signs of chronic stress, unlike other species in which permanent alterations in stress responses have been documented, new research from an Indiana University anthropologist has found.
IU anthropologist Michael P. Muehlenbein can't say yet what makes the wild orangutans of Borneo deal with stress differently than other species in other locations, but an analysis of orangutan stress hormone levels recorded before, during and ...
Researchers develop graphene supercapacitor holding promise for portable electronics
2012-03-19
Electrochemical capacitors (ECs), also known as supercapacitors or ultracapacitors, differ from regular capacitors that you would find in your TV or computer in that they store substantially higher amounts of charges. They have garnered attention as energy storage devices as they charge and discharge faster than batteries, yet they are still limited by low energy densities, only a fraction of the energy density of batteries. An EC that combines the power performance of capacitors with the high energy density of batteries would represent a significant advance in energy storage ...
A wandering mind reveals mental processes and priorities
2012-03-19
MADISON – Odds are, you're not going to make it all the way through this article without thinking about something else.
In fact, studies have found that our minds are wandering half the time, drifting off to thoughts unrelated to what we're doing – did I remember to turn off the light? What should I have for dinner?
A new study investigating the mental processes underlying a wandering mind reports a role for working memory, a sort of a mental workspace that allows you to juggle multiple thoughts simultaneously.
Imagine you see your neighbor upon arriving home one ...
Process makes polymers truly plastic
2012-03-19
DURHAM, N.C. -- Just as a chameleon changes its color to blend in with its environment, Duke University engineers have demonstrated for the first time that they can alter the texture of plastics on demand, for example, switching back and forth between a rough surface and a smooth one.
By applying specific voltages, the team has also shown that it can achieve this control over large and curved surface areas.
"By changing the voltage applied to the polymer, we can alter the surface from bumpy to smooth and back again," said Xuanhe Zhao, assistant professor of mechanical ...
Combination treatment in mice shows promise for fatal neurological disorder in kids
2012-03-19
Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and paralyzed. Most die by age 5.
There are no effective treatments for the disease, which can also strike older children. And several therapeutic approaches, evaluated in mouse models and in young children, have produced disappointing results.
But now, working in mice with the infantile form of Batten disease, scientists at Washington University School of Medicine in St. Louis ...
Fraser Yachts: Global Charter Options 2012
2012-03-19
Motor yacht IONIAN PRINCESS is a luxury yacht for charter based in Athens and can be chartered in Greece or anywhere on the Mediterranean this summer. Able to accommodate 12 guests in elegant yet comfortable quarters the motor yacht IONIAN PRINCESS is an exceptional vessel to sail upon.
Charter guests can choose to dine in one of three designated areas. One option is the sundeck, complete with barbeque; alternatively the aft deck of the sky lounge offers fantastic views or, for more formal dining there is the main salon. Appointed with only the finest of materials throughout ...
Cancer cells send out the alarm on tumor-killing virus
2012-03-19
COLUMBUS, Ohio – Brain-tumor cells that are infected with a cancer-killing virus release a protein "alarm bell" that warns other tumor cells of the impending infection and enables them to mount a defense against the virus, according to a study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
The infected tumor cells release a protein called CCN1 into the narrow space between cells where it initiates an antiviral response. The response limits the spread ...
Biomarkers: New tools of modern medicine
2012-03-19
Philadelphia, PA, March 15, 2012 – Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.
In a commentary introducing this single-topic issue, Nikolaos G. Frangogiannis, MD, The Wilf Family Cardiovascular ...
Study looks at discrimination's impact on smoking
2012-03-19
Smoking, the leading preventable cause of mortality in the United States, continues to disproportionately impact lower income members of racial and ethnic minority groups.
In a new study published in the American Journal of Public Health, Jason Q. Purnell, PhD, assistant professor at the Brown School at Washington University in St. Louis, looked at how perceived discrimination influences smoking rates among these groups.
"We found that regardless of race or ethnicity, the odds of current smoking were higher among individuals who perceived that they were treated differently ...
LAST 30 PRESS RELEASES:
AASM introduces new patient-reported outcome tool for sleep apnea
Breakthrough in indole chemistry could accelerate drug development
Gut check: Glycemic control, not body weight, may sway how we choose what to eat
Scientists date the origin of Jupiter by studying the formation of “molten rock raindrops”
Chemists develop molecule for important step toward artificial photosynthesis
Dynamic duo: a powerful pair of tools to learn about cells
Scientists discover new '3D genome organizer' linked to fertility and cancer
Mediterranean diet may offset genetic risk of Alzheimer's
New study reveals the role of subtle changes of Northern Westerlies in the East Asian monsoon variability
Are patients with advanced cancer receiving treatment aligned with their goals?
Genetic testing of IVF embryos helps women over 35 conceive faster
Survey: People not aware knee, groin pain can be signs of hip problems
New guideline offers menu of options to help people quit smoking tobacco
"Turning spin loss into energy", developing a key technology for ultra-low power next-generation information devices
Evidence, not ideology, must guide preventive health care
Kids in disadvantaged zip codes face up to 20 times higher odds of gun injuries
Gun injury odds up to 20x higher for kids in disadvantaged ZIP codes
Younger men have higher risk for mortality and cardiovascular disease for type 2 diabetes than type 1 diabetes; whereas for women type 1 diabetes outcomes are worse at all ages
Freeze-framing the cellular world to capture a fleeting moment of cellular activity
Computer hardware advance solves complex optimization problems
SOX2: a key player in prostate cancer progression and treatment resistance
Unlocking the potential of the non-coding genome for precision medicine
Chitinase-3-like protein 1: a novel biomarker for liver disease diagnosis and management
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 22, 2025
Charisma Virtual Social Coaching named a finalist for Global Innovation Award
From the atmosphere to the abyss: Iron's role in Earth's climate history
US oil and gas air pollution causes unequal health impacts
Scientists reveal how microbes collaborate to consume potent greenhouse gas
UMass Amherst kinesiologist receives $2 million ‘outstanding researcher’ award from NIH
Wildfire peer review report for land Brandenburg, Germany, is now online
[Press-News.org] Dr. Rowan Chlebowski: Effects of estrogen alone vs. estrogen plus progestin on breast cancer riskMenopausal hormone therapy and breast cancer risk: Emerging evidence from randomized trials